ANN ARBOR, Mich., April 1, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of expanded patient-specific cellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that company president and CEO Tim Mayleben will speak at the 10th Annual Needham & Company Healthcare Conference, which is being held April 5-6, 2011, at The New York Palace Hotel in New York City.
